Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela C Moga

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of the American Medical Directors Association|May 4, 2013
Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living CentersDaniela C Moga, Ryan M Carnahan, Brian C Lund, et al.
Pharmacoepidemiology and Drug Safety|March 27, 2026
Curriculum in Pharmacoepidemiology Training Programs: A Cross-Sectional Study to Assess Educational Needs and Alignment With Core CompetenciesAmie Goodin, Deborah Layton, Ryan Chung, et al.
Journal of Alzheimer'S Disease : JAD|May 30, 2023
Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic ChangesJing Di, Ruth S Nelson, Gregory A Jicha, et al.
Journal of Addiction Medicine|April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased MortalityFeitong Lei, Michelle R Lofwall, Jana McAninch, et al.
Trials|January 1, 2020
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocolDaniela C Moga, Brooke F Beech, Erin L Abner, et al.
BMJ Open|March 25, 2021
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment toolsElvira D'Andrea, Lydia Vinals, Elisabetta Patorno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancerElizabeth A Chrischilles, Jane F Pendergast, Katherine L Kahn, et al.
JAMA Ophthalmology|March 16, 2013
Automated analysis of retinal images for detection of referable diabetic retinopathyMichael D Abràmoff, James C Folk, Dennis P Han, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2025
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed GuidanceKaleen N Hayes, Joshua D Niznik, Danijela Gnjidic, et al.
Urogynecology (Philadelphia, Pa.)|December 22, 2022
Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary ReportKatherine L Dengler, Rachel A High, Daniela C Moga, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of the American Medical Directors Association|May 4, 2013
Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living CentersDaniela C Moga, Ryan M Carnahan, Brian C Lund, et al.
Pharmacoepidemiology and Drug Safety|March 27, 2026
Curriculum in Pharmacoepidemiology Training Programs: A Cross-Sectional Study to Assess Educational Needs and Alignment With Core CompetenciesAmie Goodin, Deborah Layton, Ryan Chung, et al.
Journal of Alzheimer'S Disease : JAD|May 30, 2023
Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic ChangesJing Di, Ruth S Nelson, Gregory A Jicha, et al.
Journal of Addiction Medicine|April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased MortalityFeitong Lei, Michelle R Lofwall, Jana McAninch, et al.
Trials|January 1, 2020
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocolDaniela C Moga, Brooke F Beech, Erin L Abner, et al.
BMJ Open|March 25, 2021
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment toolsElvira D'Andrea, Lydia Vinals, Elisabetta Patorno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancerElizabeth A Chrischilles, Jane F Pendergast, Katherine L Kahn, et al.
JAMA Ophthalmology|March 16, 2013
Automated analysis of retinal images for detection of referable diabetic retinopathyMichael D Abràmoff, James C Folk, Dennis P Han, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2025
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed GuidanceKaleen N Hayes, Joshua D Niznik, Danijela Gnjidic, et al.
Urogynecology (Philadelphia, Pa.)|December 22, 2022
Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary ReportKatherine L Dengler, Rachel A High, Daniela C Moga, et al.
Pageof 7